The CRUK Imperial Centre is part of a national network of 14 Centres, funded by CRUK, which aim to accelerate the progress of lab-based research and discoveries into clinical benefit for cancer patients.
The CRUK Imperial Centre is partnership between Imperial college London, Imperial college Healthcare NHS trust, Cancer Research UK and Imperial Experimental Cancer Medicine Centre (ECMC). The Centre funding was renewed in 2017 with a new mission to emphasise convergence science. The goal of our Centre is to facilitate collaborations between clinicians and biologists with the physical sciences, engineering and mathematics, harnessing our world-leading research across multiple faculties at Impeial.
What we do
As Imperial College London’s Cancer Research hub, we bring together innovative research and technologies, as well as talented researchers from across the college, in a coordinated effort to tackle cancer prevention and cancer treatment. By bringing together our cancer community under one hub, we hope to develop the next generation of technologies, methodologies and therapies and rapidly translate our discoveries into greater patient benefit. In Addition, we are committed to training the next generation of convergence cancer researchers through our PhD Studentship programme.
In the CRUK Imperial Centre we are committed to working with cancer researchers from any and all scientific discipline. If you wish to discuss a research project, potential funding routes, need help finding collaborators or with preparing/reviewing an application, please contact our Translational Research Manager Mark Gurden, who has previous experience in drug discovery and managing research funding at CRUK, or the Director of Operations Chloe Stockford.
Summary overview of our objectives
Driving the research agenda at Imperial College London, emphasising multidisciplinary research that uses engineering and technology to address cancer challenges
Supporting the cancer research community, with training and development opportunities, and seed funding for new multidisciplinary projects
Creating opportunities for researchers to come together to learn and collaborate, through events, workshops, and an online cancer research network
Our partners and collaborators
Our Centre works across all Departments and Faculties at Imperial. Contact our Director of Operations Chloe Stockford or Translational Research Manager, Mark Gurden, to discuss ideas or proposals for collaboration. We have established strong collaborative relationships with the following Research Centres and Institutes:
Imperial College Academic Health Science Centre
A university-NHS partnership to enhance the translation of research discoveries into improvements in human health.
Cancer Technology Network
Brings together scientists, clinicians and engineers to forge new approaches to cancer research
Centre for Drug Discovery Science (CDDS)
Aims to address challenges in drug discovery by spanning multiple areas of science and technology.
Clinical Academic Training Office (CATO)
CATO is the centralised pan-professional academic training hub and the main point of contact for clinical academic trainees and researchers
CRUK Convergence Science Centre
A strategic partnership between the Institute of Cancer Research and Imperial College London
Experimental Cancer Medicine Centre Network (ECMC)
The ECMC network is made up of 18 adult centres and 11 paediatric locations across the UK.
EPSRC Centre for Mathematics of Precision Healthcare
Linking up mathematical, computational and medical capabilities at Imperial
The Hamlyn Centre
At the forefront of research in imaging, sensing and robotics for addressing global health challenges.
Institute of Chemical Biology Centre for Doctoral Training
Developing novel tools and technologies that can be applied to tackle biological challenges at a molecular level.
Institute for Molecular Science and Engineering
Co-ordinates a range of activities around specific grand challenges, problems and industrial needs.
NIHR Imperial Biomedical Research Centre
The NIHR Imperial BRC is a translational research partnership between Imperial College London and Imperial College Healthcare Trust
Ovarian Cancer Action Research Centre
The Ovarian Cancer Action Research Centre’s translational research is driving new and targeted treatments into the clinic.